AXIM Biotechnologies Partners with Ora, Inc. for Cannabinoid-Based Drug Development and Clinical Trials for Eye Conditions

by adminTorusBrand | Mar 23, 2017 | Axim Biotechnologies, Press Releases, Scientific Research

In order to fast-track approval of its new products, AXIM® Biotechnologies, Inc., a Medical Marijuana, Inc. investment company, has retained the services of Ora®, Inc. for the development of its cannabinoid-based eye treatments.   A global Contract Research...

Medical Marijuana, Inc. Investment AXIM Biotech Retains Ora To Manage Upcoming Product Development And Clinical Trials On Glaucoma And Dry Eye Indications

by adminTorusBrand | Mar 21, 2017 | Axim Biotechnologies, Press Releases

NEW YORK, March 21, 2017 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM®Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in...

Medical Marijuana, Inc. Subsidiary Kannaway® Announces Exclusive Red-Carpet Event in Denver, CO

by adminTorusBrand | Mar 16, 2017 | Kannaway, Press Releases

SAN DIEGO, March 16, 2017 — Medical Marijuana, Inc. (OTC: MJNA) announced today that its subsidiary, Kannaway LLC the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products is holding an exclusive Red-Carpet Event in Denver, CO., this...

Study Results: Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Announces Release of Study using its Real Scientific Hemp Oil-X™ to Treat Epileptic Children

by adminTorusBrand | Mar 14, 2017 | HempMeds Mexico, Press Releases, Scientific Research

The following information is presented for educational purposes only. Medical Marijuana Inc. provides this information to provide an understanding of the potential applications of cannabidiol. Links to third party websites do not constitute an endorsement of these...

Dope Magazine Features Medical Marijuana, Inc. Subsidiary HempMeds® Mexico In Historic ‘Look At America’s Reverse-Cannabis Pipeline’

by adminTorusBrand | Mar 8, 2017 | HempMeds Mexico, Press Releases, Scientific Research

Article Also Details Company’s Pioneering Role in Latin America’s Burgeoning Cannabis Market SAN DIEGO, March 8, 2017 — Medical Marijuana, Inc. (OTC:MJNA) announced today that its subsidiary HempMeds® Mexico, the first company to receive government...

Medical Marijuana, Inc. Investment AXIM® Biotech Announces Enrolled Patients Begin Phase II Trial For The Treatment Of Irritable Bowel Syndrome (IBS) With CanChew Plus® Cannabidiol (CBD) Chewing Gum

by adminTorusBrand | Mar 7, 2017 | Axim Biotechnologies, Press Releases

NEW YORK, March 7, 2017 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM® Biotechnologies, Inc. (AXIM® Biotech) (AXIM) has enrolled 40 patients and...